Recombinant Bacillus licheniformis tRNA pseudouridine synthase A (truA)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Bacillus licheniformis tRNA Pseudouridine Synthase A (TruA)

Recombinant Bacillus licheniformis tRNA pseudouridine synthase A (TruA) is an enzyme involved in modifying transfer RNA (tRNA). Specifically, it catalyzes the formation of pseudouridine, an isomer of the nucleoside uridine, at specific positions within tRNA molecules. TruA enzymes are essential for tRNA maturation and function, playing a crucial role in protein synthesis .

Bacillus licheniformis, a bacterium from which this TruA is derived, is known for producing antimicrobial substances and improving intestinal health .

Function and Mechanism

TruA enzymes catalyze the conversion of uridine to pseudouridine through an isomerization reaction. This modification typically occurs at specific and conserved sites in tRNA, contributing to the structural stability and functional efficiency of tRNA . The precise mechanism involves:

  1. Recognition: TruA recognizes specific tRNA substrates based on structural elements and sequence motifs.

  2. Isomerization: The enzyme facilitates the rotation of the N1-C1' glycosidic bond of uridine, converting it into a C5-C1' bond, thus forming pseudouridine.

  3. Release: The modified tRNA is released, ready to participate in protein synthesis.

Biochemical Characterization

While the provided documents do not detail the biochemical characteristics of Bacillus licheniformis TruA, information regarding similar enzymes, such as leucyl-tRNA synthetase (LeuRS) from Pseudomonas aeruginosa, can provide a general understanding of enzymatic activity assays and kinetic parameters .

Relevant kinetic parameters include $$K_M$$ (Michaelis constant) and $$k_{cat}$$ (catalytic rate constant), which quantify the enzyme's affinity for its substrates and the rate at which it catalyzes the reaction, respectively . For instance, studies on P. aeruginosa LeuRS determined $$K_M$$ values for interactions with leucine, ATP, and tRNA to be 6.5 μM, 330 μM, and 3.0 μM, respectively .

Role in Antimicrobial Activity and Intestinal Health

Bacillus licheniformis exhibits antimicrobial activity against various bacteria, including Staphylococcus aureus and Salmonella enterica . It produces bacteriocins and antibacterial peptides, such as lichenin and ppABP, which inhibit the growth of other microorganisms .

Moreover, Bacillus licheniformis has demonstrated the ability to improve intestinal health by reducing intestinal lesion scores and down-regulating Claudin-3 mRNA levels in the jejunum .

Relevant Data Tables

Because there is no specific data available regarding “Recombinant Bacillus licheniformis tRNA pseudouridine synthase A (truA)”, the following tables provide data for similar enzymes and antimicrobial peptides produced by Bacillus licheniformis:

Table 1: Kinetic Parameters of Pseudomonas aeruginosa Leucyl-tRNA Synthetase (LeuRS)

Substrate$$K_M$$ (μM)$$k_{cat}$$ (s^{-1}\)$$k_{cat}/K_M$$ (s^{-1}\μM^{-1}\)
ATP33046.90.14
Leucine6.559.49.2
tRNA3.00.440.15

Table 2: Antimicrobial Peptides Produced by Bacillus licheniformis

PeptideMolecular Mass (kDa)ActivitySensitivity
Bacteriocin-type<10Inhibits Gram-positive bacteria, including Staphylococcus aureus, Bacillus cereusSensitive to proteolytic enzymes
Lichenin~1.4Active against Streptococcus bovis, Ruminococcus albus, Ruminococcus avefaciens, and Eubacterium ruminantiumInactivated by proteinase K treatment
Bacteriocin~4Active against Gram-positive and Gram-negative bacteria, including Bacillus cereus, Staphylococcus aureus, Listeria monocytogenes, Escherichia coli, Streptococcus equi, and Salmonella spp.Activity lost after digestion by pronase
ppABP3.0–3.5Inhibitory activity against Gram-positive and Gram-negative food-borne and human pathogensCompletely abolished by proteinase K
Licheniformins3.8, 4.4, 4.8Bacteriostatic activity against Mycobacterium tuberculosis, Staphylococcus aureus, and Escherichia coli
SubtilicheninN/AActs on cell wall synthesis
Bacteriocin6.5, 3.5Inhibitory activity against Micrococcus luteus, Staphylococcus aureus, Klebsiella sp., Aeromonas hydrophila, Listeria monocytogenes, and Salmonella typhimuriumActivities lost upon exposure to proteinase K

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless otherwise requested. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is crucial for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. Please specify your desired tag type for preferential development.
Synonyms
truA; BLi00166; BL01020; tRNA pseudouridine synthase A; EC 5.4.99.12; tRNA pseudouridine(38-40) synthase; tRNA pseudouridylate synthase I; tRNA-uridine isomerase I
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-247
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / NBRC 12200 / NCIMB 9375 / NRRL NRS-1264 / Gibson 46)
Target Names
truA
Target Protein Sequence
MRMKCTISYD GHLFYGYQVQ PGQRTIQDEL EKALQTLHKA KERIPVVSSG RTDSGVHAVG QTIHFDSPLS IPEAKWPYAL NALLPDDISV RKAEAVNDQF HARFSAKRKE YRYMIYRGRH PDVFKRYYAY HVPYDLDMEK VKEASRYLVG THDFTSFCAT KTEVKDKVRT VHELEWSDTG DGLQMRIVGS GFLYNMVRII AGTLLDVGTG KFSPGDIEKM ILAKNRDAAG RTAPAHGLYL WRVIYDN
Uniprot No.

Target Background

Function

Pseudouridine formation at positions 38, 39, and 40 within the anticodon stem and loop of transfer RNAs.

Database Links
Protein Families
TRNA pseudouridine synthase TruA family

Q&A

What is tRNA Pseudouridine Synthase A (truA) and what is its significance in Bacillus licheniformis?

TruA is an enzyme responsible for catalyzing the conversion of uridine to pseudouridine at specific positions in tRNA molecules. This post-transcriptional modification is critical for maintaining proper tRNA structure and function. In Bacillus licheniformis, as in other bacteria, truA plays an essential role in ensuring translational accuracy and efficiency by stabilizing the tertiary structure of tRNA.

The pseudouridine modification occurs at positions 38-40 in the anticodon stem-loop of tRNA, affecting codon-anticodon interactions during protein synthesis. Unlike the novel class of pseudouridine synthases described by Kaya and others that target position 13 (renamed TruD) , truA has a different substrate specificity and belongs to one of the four classical subgroups of pseudouridine synthases with characteristic amino acid sequence motifs.

How does the true experimental design approach benefit studies of recombinant truA?

True experimental design provides the most rigorous methodological framework for establishing cause-effect relationships in truA research. When studying recombinant B. licheniformis truA, this approach requires:

  • Random assignment of experimental units

  • Controlled manipulation of independent variables

  • Measurement of dependent variables using objective methods

  • Inclusion of appropriate control groups 9

For example, when investigating the effects of specific mutations on truA activity, researchers should include wild-type truA as a control, randomly assign replicate reactions to different experimental conditions, and control for variables such as temperature, pH, and substrate concentration. This approach minimizes bias and confounding variables, making it possible to establish causal relationships between structural features and enzymatic function .

What expression systems are suitable for producing recombinant Bacillus licheniformis truA?

Several expression systems have been successfully employed for producing recombinant B. licheniformis proteins, which can be adapted for truA expression:

Expression HostVectorTag SystemInduction MethodAdvantagesLimitations
E. coli BL21(DE3)pET-15b(+)N-terminal His6IPTG (1 mM)High yield, easy purificationPotential protein folding issues
E. coli BL21pRSET-AN-terminal His6IPTG (1 mM)Good for small proteins (~23 kDa)Limited post-translational modifications
B. licheniformis CAIndigenousNativeNutrient-dependentNative folding environmentLower yield than heterologous systems

The most commonly used system involves cloning the truA gene into the pET-15b(+) expression vector, transformation into E. coli BL21(DE3), and induction with IPTG. Purification can be accomplished using Ni-NTA agarose beads, with elution using 250 mM imidazole (pH 8.0) .

For protein purification, cell lysates should be separated from debris by centrifugation (13,000 rpm, 30 min), loaded onto a Ni-NTA column, washed extensively, and eluted with imidazole buffer. The purified protein should be dialyzed against 50 mM Tris (pH 8.0) using an appropriate ultrafilter .

What are the key considerations for designing primers for truA gene amplification?

Designing effective primers for truA gene amplification requires careful consideration of several factors:

  • Specificity: Include 18-25 nucleotides complementary to the target sequence

  • Melting temperature: Aim for 52-60°C with both primers having similar Tm values

  • Restriction sites: Add appropriate restriction sites (e.g., BamHI, XhoI) with 5-6 extra bases at the 5' end for efficient enzyme cutting

  • Start/stop codons: Ensure proper reading frame maintenance

  • GC content: Maintain 40-60% GC content for stable annealing

Based on the approach used for similar B. licheniformis genes, an effective PCR reaction might use 50 ng template DNA, 10 pmol of each primer, and a melting temperature around 52-60°C .

Example primer design strategy (adapt sequences based on the specific truA gene):

  • Forward primer: 5'-AGCGCTCTA[BamHI site]ATGAAANNNNNNNNNNNNN-3'

  • Reverse primer: 5'-GCAGTAAGC[XhoI site]CTANNNNNNNNNNNNN-3'

The amplified product should be purified, digested with the appropriate restriction enzymes, and ligated into the pre-digested expression vector .

How can researchers address contradictory data regarding truA substrate specificity and activity?

Contradictory findings regarding truA substrate specificity and activity can be systematically addressed through the following methodological approaches:

  • Experimental Standardization: Standardize reaction conditions, substrate preparation, and analytical methods across laboratories. Establish minimum information standards for reporting pseudouridylation assays, similar to those employed in other fields .

  • Multi-method Verification: Employ complementary techniques to assess pseudouridylation:

    • Mass spectrometry for direct modification detection

    • High-performance liquid chromatography for quantitative analysis

    • RNA sequencing with pseudouridine-specific chemistry

    • In vivo functional assays to correlate biochemical findings with physiological relevance

  • Systematic Mutagenesis: Create a library of truA variants with point mutations at conserved residues. The GXKD motif in motif II, particularly the aspartate residue, is essential for catalytic activity in related pseudouridine synthases . Systematic mutagenesis of this and other conserved motifs can resolve discrepancies about the catalytic mechanism.

  • Controlled Variable Analysis: When contrasting results emerge, conduct side-by-side experiments manipulating key variables:

VariableSystematic RangeMeasurement MethodExpected Impact
Mn²⁺ concentration0-5 mMActivity assayOptimal at ~1 mM
Temperature30-60°CActivity assayOptimal at 40-45°C
pH6.0-9.0Activity assayOptimal at pH 7.5-8.0
tRNA substrateDifferent tRNA speciesModification analysisSubstrate preference patterns
  • Context Dependency Classification: Categorize contradictory findings according to whether they arise from differences that are: (a) internal to the organism (genetic background), (b) external experimental conditions, (c) endogenous/exogenous factors, (d) known controversies in the field, or (e) methodological inconsistencies .

By applying these systematic approaches, researchers can reconcile apparently contradictory data and develop a more nuanced understanding of truA's function in B. licheniformis.

What are the optimal conditions for assessing recombinant truA enzymatic activity?

The optimal conditions for assessing recombinant B. licheniformis truA enzymatic activity should be determined through systematic optimization experiments based on approaches used for related enzymes:

Reaction Buffer Components:

  • 50 mM Tris-HCl (pH 7.5-8.0)

  • 100 mM NH₄Cl

  • 5 mM MgCl₂

  • 1 mM DTT

  • 1 mM Mn²⁺ (critical cofactor)

Optimal Environmental Conditions:

  • Temperature: 40-45°C (matching B. licheniformis physiological temperature)

  • pH: 7.5-8.0

  • Incubation time: 30-60 minutes for initial rate determination

Substrate Considerations:

  • Purified tRNA substrate (0.5-2 μM)

  • ATP (1 mM) may enhance activity

  • Ensure absence of RNase contamination

Activity Determination Methods:

  • Tritium release assay using [³H]-labeled tRNA

  • HPLC analysis of nucleosides after enzymatic hydrolysis

  • Mass spectrometry to detect pseudouridine formation

  • Thin-layer chromatography after nuclease digestion

Control experiments should include heat-inactivated enzyme, reactions without metal cofactors, and parallel assays with known active and inactive enzyme variants. Based on studies of related enzymes, the specific activity is expected to peak at 40-45°C and pH 7.5-8.0 in the presence of 1.0 mM Mn²⁺ .

How can researchers distinguish between the functions of truA and other tRNA modification enzymes in B. licheniformis?

Distinguishing between the functions of truA and other tRNA modification enzymes requires a multi-faceted experimental approach:

  • Gene Deletion and Complementation Studies: Generate truA deletion mutants in B. licheniformis and assess the specific changes in tRNA modification patterns. Complementation with plasmid-borne truA should restore the wild-type modification profile. This approach successfully revealed the specific role of YrvO (a cysteine desulfurase) and MnmA (a thiouridylase) in tRNA modification in the related organism B. subtilis .

  • Substrate Specificity Analysis: Conduct comparative in vitro modification assays using purified recombinant truA and other modification enzymes with various tRNA substrates:

EnzymeExpected ModificationTarget PositiontRNA SpecificityDetection Method
TruAPseudouridine (Ψ)38-40Multiple tRNAsHPLC, MS/MS
MnmA2-thiouridine (s²U)34tRNA^Glu, tRNA^Gln, tRNA^LysHPLC, ³⁵S labeling
TruDPseudouridine (Ψ)13Specific tRNAsHPLC, MS/MS
ThiI4-thiouridine (s⁴U)8Multiple tRNAsHPLC, ³⁵S labeling
  • Sequential Modification Analysis: Determine the order of modifications by using partially modified tRNAs as substrates. Evidence from B. subtilis suggests that in the case of U34 modification, thiolation occurs first, establishing a sequential order in the modification pathway .

  • Physiological Response Studies: Monitor changes in tRNA modification levels under various stress conditions. For example, 2-thiouridine tRNA modification in B. subtilis is responsive to sulfur availability, indicating a functional role during nutrient starvation . Similar experiments could reveal physiological contexts where truA-mediated pseudouridylation is particularly important.

  • Protein Interaction Studies: Identify potential protein-protein interactions between truA and other components of the tRNA modification machinery using techniques such as pull-down assays, co-immunoprecipitation, or bacterial two-hybrid systems. This could reveal whether truA functions independently or as part of a larger complex.

By employing these complementary approaches, researchers can specifically attribute tRNA modification functions to truA versus other enzymes in the B. licheniformis tRNA modification network.

What technology readiness assessment (TRA) considerations apply to recombinant truA research projects?

When evaluating the maturity of recombinant truA research projects, technology readiness levels (TRLs) provide a systematic framework for assessment:

TRLDescriptiontruA Research Milestone ExamplesEvidence Requirements
1Basic principles observedIdentification of truA gene in B. licheniformis genomePublished genomic analysis, sequence comparison
2Technology concept formulatedHypothesis of truA function based on homologyAnalytical studies, comparative sequence analysis
3Experimental proof of conceptDemonstration of pseudouridylation activity in vitroLaboratory results showing critical properties
4Technology validated in labReproducible activity with defined substratesComponent validation in laboratory environment
5Technology validated in relevant environmentActivity under physiological conditionsResults in environment representative of actual conditions
6Demonstration in relevant environmentFunction demonstrated in cell extractsSystem/subsystem model or prototype demonstration

For truA research projects, Critical Technology Elements (CTEs) that should be specifically assessed include:

  • Protein Expression and Purification: The ability to produce active recombinant truA consistently

  • Enzymatic Activity Assays: Reliable methods to measure pseudouridylation activity

  • Substrate Specificity Determination: Clear identification of target tRNAs and modification positions

  • Structural Characterization: Determination of protein structure and active site configuration

To advance from TRL 3 to TRL 5, researchers must demonstrate that truA functions not only under optimized laboratory conditions but also in environments that represent the physiological context in which the enzyme naturally operates. This includes demonstrating activity at physiological temperature, pH, ion concentrations, and in the presence of potential cellular inhibitors .

How can researchers address potential contradictions between in vitro and in vivo findings for truA function?

Contradictions between in vitro and in vivo findings for truA function can be systematically addressed through the following methodological approaches:

  • Physiologically Relevant Conditions: Adjust in vitro reaction conditions to better mimic the cellular environment:

    • Use physiological concentrations of ions, substrates, and potential regulators

    • Account for macromolecular crowding by adding crowding agents

    • Consider the effects of cellular pH and temperature

    • Include potential protein partners present in vivo

  • Comparative Cell-Free Systems: Employ increasingly complex experimental systems to bridge the gap between purified component assays and whole-cell studies:

    • Purified enzyme with synthetic substrates

    • Purified enzyme with cellular tRNA extracts

    • Cell extracts with endogenous or added truA

    • Permeabilized cells with controlled component access

  • Conditional Expression Systems: Develop systems for controlling truA expression levels in vivo:

    • Inducible promoters for temporal control

    • Temperature-sensitive variants for conditional activity

    • Degron-tagged variants for targeted degradation

  • Direct In-Cell Activity Measurements: Implement methods for measuring pseudouridylation directly in living cells:

    • RNA-seq based approaches for detecting pseudouridine

    • Fluorescent reporter systems linked to pseudouridylation status

    • Mass spectrometry of tRNA isolated under various conditions

  • Integrative Data Analysis: Apply systematic frameworks for categorizing and resolving apparent contradictions:

Contradiction CategoryExample for truAResolution Approach
Internal to organismActivity differs between strainsGenetic background analysis
External conditionsTemperature affects activity differentlyDefine temperature response curves
Endogenous/exogenous factorsNutrient conditions alter functionControlled nutrient experiments
Known controversyMechanism disputedStructural studies with inhibitors
Literature contradictionsConflicting reported specificitiesStandardized comparative assays

By applying these approaches, researchers can develop a more integrated understanding of truA function that reconciles in vitro biochemical properties with in vivo physiological roles .

What computational approaches can be used to predict truA substrate specificity and functional properties?

Advanced computational approaches can significantly enhance the study of truA substrate specificity and functional properties:

  • Homology Modeling and Molecular Dynamics:

    • Generate structural models based on crystallized pseudouridine synthases

    • Perform molecular dynamics simulations to analyze:

      • Enzyme flexibility and conformational changes

      • Binding pocket dynamics

      • Water and ion coordination networks

      • Substrate recognition mechanisms

  • Machine Learning for Substrate Prediction:

    • Train algorithms on known pseudouridine sites using features such as:

      • Sequence context (±10 nucleotides)

      • RNA secondary structure elements

      • Solvent accessibility

      • Conservation patterns across species

    • Validate predictions with experimental verification

    • Refine models iteratively with new empirical data

  • Quantum Mechanics/Molecular Mechanics (QM/MM) Simulations:

    • Model the catalytic mechanism at atomic resolution

    • Calculate energy barriers for reaction steps

    • Predict effects of mutations on catalysis

    • Identify critical catalytic residues (the GXKD motif, particularly the aspartate residue, is likely essential for activity)

  • Network Analysis of tRNA Modification Pathways:

    • Map interactions between different modification enzymes

    • Predict effects of truA activity on other modifications

    • Identify potential regulatory nodes

    • Simulate the effects of environmental perturbations

  • Comparative Genomics for Functional Inference:

    • Analyze truA conservation across Bacillus species

    • Identify co-evolving genes that may function together

    • Determine substitution patterns that maintain function

    • Correlate genetic variations with physiological adaptations

These computational approaches should be integrated with experimental validation to create an iterative feedback loop that enhances both prediction accuracy and experimental design. For instance, computational predictions of substrate specificity can guide the design of targeted biochemical assays, while experimental data can refine computational models.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.